PHARMA ACTIVE AS

2019 SKEDSMOKORSET

Finances

Return on Equity

−2,48 %

Current Ratio

6,3

Debt-to-Equity Ratio

0,34

Key figures (NOK)	2022	2021	2020	2019
Revenue	1 009 000	455 000	288 000	217 000
Net Income	−1 011 000	7 048 000	5 615 000	6 493 000
Total Assets	61 496 000	60 302 000	54 714 000	49 089 000
Total Equity	40 806 000	42 241 000	37 980 000	45 355 000

Income (NOK)	2022	2021	2020	2019
Revenue	1 009 000	455 000	288 000	217 000
Expenditure	455 000	138 000	186 000	315 000
Operating Profit	555 000	317 000	101 000	−98 000
Financial Income	3 509 000	7 038 000	6 614 000	6 800 000
Financial Costs	4 935 000	308 000	1 101 000	209 000
Financial Balance	−1 426 000	6 730 000	5 513 000	6 591 000
Earnings Before Tax	−871 000	7 048 000	5 615 000	6 493 000
Tax	140 000	0	0	0
Net Income	−1 011 000	7 048 000	5 615 000	6 493 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	18 925 000	18 569 000	1 313 000	187 000
Total Current Assets	42 571 000	41 733 000	53 401 000	48 902 000
Total Assets	61 496 000	60 302 000	54 714 000	49 089 000
Total Retained Equity	40 706 000	42 141 000	37 880 000	45 255 000
Total Equity	40 806 000	42 241 000	37 980 000	45 355 000
Total Long-Term Debt	13 928 000	15 100 000	2 323 000	0
Total Current Debt	6 762 000	2 961 000	14 411 000	3 734 000
Total Equity and Debt	61 496 000	60 302 000	54 714 000	49 089 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	1 009 000	455 000	158 000	217 000
Other Income	0	0	130 000	0
Revenue	1 009 000	455 000	288 000	217 000
Cost of Goods Sold	0	0	0	0
Salary Costs	0	0	0	0
Depreciation	44 000	0	0	100 000
Impairment	0	0	0	0
Expenditure	455 000	138 000	186 000	315 000
Operating Profit	555 000	317 000	101 000	−98 000
Financial Income	3 509 000	7 038 000	6 614 000	6 800 000
Financial Costs	4 935 000	308 000	1 101 000	209 000
Financial Balance	−1 426 000	6 730 000	5 513 000	6 591 000
Dividends	0	0	1 700 000	0
Net Income	−1 011 000	7 048 000	5 615 000	6 493 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	556 000	0	0	0
Total Tangible Assets	556 000	0	0	0
Total Fiancial Fixed Assets	18 369 000	18 569 000	1 313 000	187 000
Total Fixed Assets	18 925 000	18 569 000	1 313 000	187 000
Stock	0	0	0	0
Total Investments	25 747 000	20 098 000	43 450 000	44 953 000
Cash, Bank	777 000	2 625 000	2 000	319 000
Total Current Assets	42 571 000	41 733 000	53 401 000	48 902 000
Total Assets	61 496 000	60 302 000	54 714 000	49 089 000
Total Equity	40 806 000	42 241 000	37 980 000	45 355 000
Short-Term Group Debt	0	2 787 000	11 290 000	0
Total Long-Term Debt	13 928 000	15 100 000	2 323 000	0
Creditors	8 000	77 000	30 000	24 000
Unpaid Taxes	629 000	0	10 000	13 000
Dividends	0	0	1 700 000	0
Other Current Debt	39 000	96 000	378 000	64 000
Total Current Debt	6 762 000	2 961 000	14 411 000	3 734 000
Total Equity and Debt	61 496 000	60 302 000	54 714 000	49 089 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−2,48 %	16,69 %	14,78 %	14,32 %
Debt-to-Equity Ratio	0,34	0,36	0,06	0
Operating Profit Margin	55 %	69,67 %	35,07 %	−45,16 %
Current Ratio	6,3	14,09	3,71	13,1
Quick Ratio	6,3	14,09	3,71	13,1
Equity Ratio	0,66	0,7	0,69	0,92
Gross Profit Margin	100 %	100 %	100 %	100 %